文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

特发性与系统性硬化症相关肺动脉高压:人口学、血流动力学及MRI特征与结局比较

Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
PubMed 文献 · Chest · 2017-02-20
一句话结论SSc-PAH中位生存仅3年,显著劣于IPAH的7.8年;年龄、SSc、DLCO、肺动脉血氧饱和度和每搏输出量为独立预后因素。

该研究纳入651例IPAH或SSc相关毛细血管前肺动脉高压患者,排除肺病或≥2项左心疾病危险因素后主要分析集为375例,并行心脏磁共振(CMR)亚组分析。SSc-PAH患者中位生存3年,IPAH为7.8年(P < .001)。SSc-PAH患者年龄更大、血流动力学较轻但DLCO更低。独立预后因素为年龄、SSc、DLCO、肺动脉血氧饱和度和每搏输出量。IPAH与SSc-PAH的PVR与顺应性关系无差异,mPAP与sPAP关系相似。

要点

  • SSc-PAH中位生存3年,IPAH中位生存7.8年,差异有统计学意义(P < .001)。
  • SSc-PAH患者年龄更大、血流动力学较轻但DLCO更低,独立预后因素包括年龄、SSc、DLCO、肺动脉血氧饱和度和每搏输出量。
  • 排除阻力正常或仅轻度升高者后,IPAH与SSc-PAH的PVR与顺应性关系无差异。
  • IPAH中mPAP与sPAP关系为mPAP = 0.61 sPAP + 2 mm Hg,SSc-PAH为mPAP = 0.58 sPAP + 2 mm Hg(与IPAH差异P = 0.095)。
  • CMR测量的心室质量指数与PVR的相关性在SSc-PAH中更强。

适用人群与场景

  • 诊断为IPAH或SSc相关毛细血管前肺动脉高压的患者。
  • 排除有肺病或≥2项左心疾病危险因素者后,主要分析集为375例。

研究设计与关键结果

  • 研究类型为队列研究,纳入651例IPAH或SSc相关毛细血管前肺动脉高压患者,主要分析集375例,并行CMR亚组分析。
  • SSc-PAH中位生存3年,IPAH中位生存7.8年(P < .001)。
  • SSc-PAH患者年龄更大、血流动力学较轻但DLCO更低。
  • 独立预后因素为年龄、SSc、DLCO、肺动脉血氧饱和度和每搏输出量。
  • 排除阻力正常或仅轻度升高者后,IPAH与SSc-PAH的PVR与顺应性关系无差异。
  • IPAH中mPAP与sPAP关系为mPAP = 0.61 sPAP + 2 mm Hg;SSc-PAH为mPAP = 0.58 sPAP + 2 mm Hg(与IPAH差异P = 0.095)。
  • CMR测量的心室质量指数与PVR的相关性在SSc-PAH中更强。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Previous studies have identified survival in systemic sclerosis (SSc)-associated pulmonary arterial hypertension (SSc-PAH) as being worse than in idiopathic pulmonary arterial hypertension (IPAH). We investigated differences between these conditions by comparing demographic, hemodynamic, and radiological characteristics and outcomes in a large cohort of incident patients.

METHODS: Six hundred fifty-one patients diagnosed with IPAH or SSc-associated precapillary pulmonary hypertension were included. Patients with pulmonary disease or two or more risk factors for left heart disease were identified, leaving a primary analysis set of 375 subjects. Subgroup analysis using cardiac magnetic resonance (CMR) imaging was performed.

RESULTS: Median survival was 7.8 years in IPAH and 3 years in SSc-PAH (P < .001). Patients with SSc-PAH were older with less severe hemodynamics but lower gas transfer (diffusing capacity for carbon monoxide [Dlco]). Independent prognostic factors were age, SSc, Dlco, pulmonary artery saturation, and stroke volume. After excluding patients with normal or only mildly elevated resistance, there was no difference in the relationship between pulmonary vascular resistance (PVR) and compliance in IPAH and SSc-PAH. The relationship between mean pulmonary arterial pressure (mPAP) and systolic pulmonary arterial pressure (sPAP) in IPAH was identical to that previously reported (mPAP = 0.61 sPAP + 2 mm Hg). The relationship in SSc-PAH was similar: mPAP = 0.58 sPAP + 2 mm Hg (P value for difference with IPAH = 0.095). The correlation between ventricular mass index assessed at CMR imaging and PVR was stronger in SSc-PAH.

CONCLUSIONS: The reasons for poorer outcomes in SSc-PAH are likely to be multifactorial, including but not limited to older age and reduced gas transfer.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Ramjug S, Hussain N, Hurdman J, et al. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes. Chest. 2017. PMID: 28223154. doi:10.1016/j.chest.2017.02.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。